Cargando…

Elevated pretreatment plasma D-dimer levels and platelet counts predict poor prognosis in pancreatic adenocarcinoma

This retrospective study was conducted to evaluate the prognostic significance of the preoperative plasma D-dimer levels and platelet counts in patients with pancreatic adenocarcinoma. A total of 168 consecutive locally advanced pancreatic adenocarcinoma patients who underwent intensity modulated ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Peng, Zhu, Yuan, Liu, Luying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461118/ https://www.ncbi.nlm.nih.gov/pubmed/26082650 http://dx.doi.org/10.2147/OTT.S82329

Ejemplares similares

Elevated pretreatment platelet distribution width and platelet count predict poor prognosis in nasopharyngeal carcinoma
por: Xie, XueCheng, et al.
Publicado: (2017)

Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy
por: Liu, Peng, et al.
Publicado: (2015)

Elevated plasma D-dimer levels are associated with the poor prognosis of critically ill children
por: Wang, Guan, et al.
Publicado: (2022)

High pretreatment plasma D-dimer levels predict poor prognosis in gastrointestinal cancers: A meta-analysis
por: Rong, Guoyi, et al.
Publicado: (2019)

Elevated Platelet Count Predicts Poor Prognosis in Breast Cancer Patients with Supraclavicular Lymph Node Metastasis
por: Liu, Shaoqing, et al.
Publicado: (2020)

High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension
por: Sakurai, Manabu, et al.
Publicado: (2015)

Poor prognostic role of the pretreatment platelet counts in colorectal cancer: A meta-analysis
por: Rao, Xu-Dong, et al.
Publicado: (2018)

Does pretreatment elevated calcitonin level cause the poor prognosis in patients with medullary thyroid cancer?
por: Zhang, Han, et al.
Publicado: (2022)

Elevated red cell distribution width to platelet count ratio predicts poor prognosis in patients with breast cancer
por: Takeuchi, Hideya, et al.
Publicado: (2019)

Prognostic significance of pretreatment elevated platelet count in patients with colorectal cancer: a meta-analysis
por: Long, Yu, et al.
Publicado: (2016)

Elevated platelet distribution width predicts poor prognosis in hilar cholangiocarcinoma
por: Li, Bei, et al.
Publicado: (2020)

Elevated mean platelet volume predicts poor prognosis in colorectal cancer
por: Li, Na, et al.
Publicado: (2017)

Impact of pretreatment plasma D-dimer levels and its perioperative change on prognosis in operable esophageal squamous cell carcinoma
por: Li, Jianbo, et al.
Publicado: (2017)

Elevated Platelet Distribution Width Predicts Poor Prognosis in Gallbladder Carcinoma
por: Liu, Fei, et al.
Publicado: (2021)

Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
por: Dong, Qian, et al.
Publicado: (2014)

Elevated Pretreatment Plasma Oncostatin M Is Associated With Poor Biochemical Response to Infliximab
por: Minar, Phillip, et al.
Publicado: (2019)

High pretreatment plasma D-dimer levels predict poor survival in patients with diffuse large B-cell lymphoma in the real world
por: Huang, Haobo, et al.
Publicado: (2021)

Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcinoma
por: Li, Wanwan, et al.
Publicado: (2019)

Elevated plasma YKL-40 level is found in the dogs with cancer and is related to poor prognosis
por: Cheng, Kai-Chung, et al.
Publicado: (2019)

Pretreatment platelet count as a prognostic factor in patients with pancreatic cancer: a systematic review and meta-analysis
por: Chen, Sheng, et al.
Publicado: (2017)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer
por: Chen, Jie-Ping, et al.
Publicado: (2019)

Elevated levels of D-dimer in patients with COVID-19: prognosis value
por: Oualim, Sara, et al.
Publicado: (2020)

Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer
por: Choi, Chel Hun, et al.
Publicado: (2018)

Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinoma
por: Chen, Wen-Hui, et al.
Publicado: (2014)

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma
por: Bi, Xi-wen, et al.
Publicado: (2016)

Elevated plasma D-dimer levels in dermatomyositis patients with cutaneous manifestations
por: Habe, Koji, et al.
Publicado: (2019)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

Spectrophotometric determination of platelet counts in platelet-rich plasma
por: Kitamura, Yutaka, et al.
Publicado: (2018)

High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
por: Curia, Maria Cristina, et al.
Publicado: (2019)

Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
por: Wang, Lili, et al.
Publicado: (2017)

Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection
por: Shen, Shun-Li, et al.
Publicado: (2014)

Elevated D-Dimer Levels Predict a Poor Outcome in Critically Ill Patients
por: Ichkawa, Yuhuko, et al.
Publicado: (2020)

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
por: Zhang, Luan-Jing, et al.
Publicado: (2014)

Elevated glypican‐1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma
por: Lu, Haizhen, et al.
Publicado: (2017)

High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma
por: Liu, Na, et al.
Publicado: (2021)

Elevated plasma D-dimer levels are associated with short-term poor outcome in patients with acute ischemic stroke: a prospective, observational study
por: Yao, Tao, et al.
Publicado: (2019)

High Pretreatment LDH Predicts Poor Prognosis in Hypopharyngeal Cancer
por: Wu, Jialing, et al.
Publicado: (2021)

Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uoikntk355mljekilbdp1pgt2s